Investors bought shares of CME Group Inc (NASDAQ:CME) on weakness during trading on Thursday. $72.81 million flowed into the stock on the tick-up and $64.44 million flowed out of the stock on the tick-down, for a money net flow of $8.37 million into the stock. Of all stocks tracked, CME Group had the 28th highest net in-flow for the day. CME Group traded down ($1.03) for the day and closed at $181.26
Several equities analysts have recently weighed in on the stock. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, January 9th. Citigroup assumed coverage on shares of CME Group in a research note on Tuesday, November 20th. They issued a “buy” rating and a $220.00 target price for the company. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $184.00 target price on shares of CME Group in a research note on Monday, December 10th. Wells Fargo & Co boosted their price objective on shares of CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a research note on Friday, October 26th. Finally, Deutsche Bank reaffirmed a “buy” rating and set a $192.00 price objective (up previously from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Eight equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $193.00.
The company has a market cap of $61.60 billion, a P/E ratio of 38.45, a P/E/G ratio of 2.21 and a beta of 0.43. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15.
The company also recently disclosed a dividend, which was paid on Wednesday, January 16th. Investors of record on Friday, December 28th were paid a dividend of $1.75 per share. The ex-dividend date of this dividend was Thursday, December 27th. CME Group’s dividend payout ratio is currently 58.70%.
In other CME Group news, COO Julie Holzrichter sold 3,353 shares of CME Group stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $186.71, for a total transaction of $626,038.63. Following the completion of the sale, the chief operating officer now directly owns 45,627 shares in the company, valued at $8,519,017.17. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Charles P. Carey sold 2,800 shares of CME Group stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $183.45, for a total transaction of $513,660.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 58,647 shares of company stock valued at $11,107,550. 0.43% of the stock is currently owned by company insiders.
A number of institutional investors have recently made changes to their positions in CME. Ipswich Investment Management Co. Inc. bought a new stake in shares of CME Group in the 4th quarter worth approximately $47,000. Contravisory Investment Management Inc. lifted its holdings in shares of CME Group by 197.6% in the 4th quarter. Contravisory Investment Management Inc. now owns 253 shares of the financial services provider’s stock worth $48,000 after acquiring an additional 168 shares during the last quarter. Alpha Windward LLC lifted its holdings in shares of CME Group by 820.0% in the 4th quarter. Alpha Windward LLC now owns 322 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 287 shares during the last quarter. Prime Capital Investment Advisors LLC lifted its holdings in shares of CME Group by 282.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 765 shares of the financial services provider’s stock worth $130,000 after acquiring an additional 565 shares during the last quarter. Finally, Honkamp Krueger Financial Services Inc. bought a new stake in shares of CME Group in the 3rd quarter worth approximately $132,000. Institutional investors and hedge funds own 85.68% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by BBNS and is the property of of BBNS. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://baseballnewssource.com/2019/01/19/traders-buy-cme-group-cme-on-weakness/3152611.html.
CME Group Company Profile (NASDAQ:CME)
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Story: Purposes and Functions of the Federal Reserve
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.